J&J Ethicon launch of ThermaChoice uterine balloon backed by direct sales force of roughly 60 reps.
This article was originally published in The Gray Sheet
Executive Summary
ETHICON's LAUNCH OF THERMACHOICE UTERINE BALLOON THERAPY SYSTEM is being backed by a roughly 60-rep sales force specializing in women's health products. J&J began selling the device to U.S. gynecologists immediately following FDA approval Dec. 12.